Slonim A D, Ognibene F P
Critical Care Medicine Department, Warren G. Magnuson Clinical Center, National Institutes of Health, Bethesda, MD 20892-1662, USA.
Crit Care Med. 1998 Nov;26(11):1900-4. doi: 10.1097/00003246-199811000-00036.
To evaluate the effectiveness and safety of pediatric procedures performed by adult critical care practitioners, using the combination of ketamine and midazolam for anesthesia and sedation.
A retrospective case series.
The intensive care unit (ICU) of a 325-bed tertiary research hospital.
Individuals from 1 to 18 yrs of age who had intravenous midazolam sedation and ketamine anesthesia administered while undergoing lumbar puncture, bone biopsy, central venous catheter placement, liver biopsy, thoracentesis, or bone marrow aspirate/biopsy.
None.
A retrospective chart review was performed. The dosages of medications used were tabulated, and milligram per kilogram dosages were calculated. The procedures performed, their durations, and any complications of the anesthesia and sedation were noted. These complications included: oxygen desaturations <90%, vital sign alterations requiring intervention, rashes, subjective complaints of dizziness by the patient, and emergence reactions to ketamine. A total of 127 pediatric patients were admitted to the ICU sedation area for a total of 295 procedures. All patients received ketamine and midazolam intravenously in divided doses and titrated to effect. A total of nine complications were observed. These complications included oxygen desaturation <90% (n = 1), vital sign alterations requiring treatment (n = 3), rash (n = 2), dizziness (n = 1), wheezing (n = 1), and emergence reaction (n = 1). No patient required admission to the ICU because of a complication. There were no episodes of bradycardia or other cardiopulmonary compromise.
Pediatric anesthesia and sedation, using ketamine and midazolam, can be performed in a designated monitored setting, outside of the operating room, by experienced personnel, including nonpediatricians. This therapeutic combination allows painful procedures to be performed with less anxiety and discomfort. In experienced hands, a limited number of side effects occur.
评估成人重症监护从业者使用氯胺酮和咪达唑仑联合进行麻醉和镇静实施儿科操作的有效性和安全性。
一项回顾性病例系列研究。
一家拥有325张床位的三级研究医院的重症监护病房(ICU)。
年龄在1至18岁之间,在接受腰椎穿刺、骨活检、中心静脉导管置入、肝活检、胸腔穿刺或骨髓抽吸/活检时接受静脉咪达唑仑镇静和氯胺酮麻醉的个体。
无。
进行了回顾性病历审查。记录所用药物的剂量,并计算每千克体重的毫克剂量。记录所实施的操作、操作持续时间以及麻醉和镇静的任何并发症。这些并发症包括:氧饱和度<90%、需要干预的生命体征改变、皮疹、患者主观的头晕主诉以及氯胺酮的苏醒反应。共有127名儿科患者入住ICU镇静区,共进行了295项操作。所有患者均静脉分次给予氯胺酮和咪达唑仑,并根据效果进行滴定。共观察到9例并发症。这些并发症包括氧饱和度<90%(n = 1)、需要治疗的生命体征改变(n = 3)、皮疹(n = 2)、头晕(n = 1)、喘息(n = 1)和苏醒反应(n = 1)。没有患者因并发症而需要入住ICU。没有发生心动过缓或其他心肺功能不全的情况。
使用氯胺酮和咪达唑仑进行儿科麻醉和镇静,可以在手术室以外的指定监测环境中,由包括非儿科医生在内的经验丰富的人员实施。这种治疗组合能使痛苦的操作在焦虑和不适较少的情况下进行。在经验丰富的人员操作下,副作用数量有限。